Riskpilot← Back to searchSign inGet full accessEnsoma ApS
APSActiveCVR 40804307Nordre Fasanvej 215Research and experimental development on natural sciences and engineering · NACE 7210Est. 20192 employeeswww.ensoma.com
Revenue 2024
DKK -3,4M
+74% vs 2023
EBITDA margin
157.1%
-43% vs 2023
Equity ratio
74.2%
Financial strength
Net profit 2024
DKK -5,4M
-73% vs 2023
| Revenue | DKK -3,4M | +74% |
| EBITDA | DKK -5,4M | -43% |
| Net profit | DKK -5,4M | -73% |
| Total assets | DKK 2,8M | +26% |
| Equity | DKK 2,1M | +38% |
| Employees | 2 | — |
Legal name
Ensoma ApS
CVR number
40804307
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
23. september 2019
Share capital
DKK 118.759
Employees
2 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af formanden for bestyrelsen i forening med et medlem af bestyrelsen.
Company purpose
Selskabets formål er at udvikle og kommercialisere medicinske lægemidler samt anden virksomhed, der står i forbindelse hermed.
Address
Nordre Fasanvej 215
Phone
+4531333544
Email
sstella@ensoma.com
Website
www.ensoma.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | -620 | -1.272 | -2.078 | -1.955 | -3.407 |
| Staff expenses | -242 | -917 | -1.317 | -1.788 | -1.945 |
| EBITDA | -861 | -2.189 | -3.395 | -3.743 | -5.352 |
| Depreciation & amort. | -0 | -12 | -32 | -122 | -803 |
| EBIT | -861 | -2.201 | -3.427 | -3.865 | -6.155 |
| Net financials | -2 | -21 | -56 | -14 | -5 |
| Profit before tax | -863 | -2.222 | -3.483 | -3.879 | -6.161 |
| Tax | -192 | -437 | -569 | -738 | -738 |
| Net profit | -671 | -1.784 | -2.914 | -3.141 | -5.423 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1.728 | 2.611 | 1.255 | 2.217 | 2.786 |
| Equity | 1.517 | 2.379 | -534 | 1.502 | 2.066 |
| Long-term debt | 0 | 0 | 1.598 | 0 | 0 |
| Short-term debt | 211 | 232 | 192 | 715 | 719 |
| Total debt | 211 | 232 | 1.790 | 715 | 719 |
EBITDA margin
-535193000.0%
This company
15.8%
Market median
-3387297568% vs market
20202024
Equity ratio
74.2%
This company
38.2%
Market median
+94% vs market
20202024
Return on equity
-262.5%
This company
18.4%
Market median
-1527% vs market
20202024
Net profit margin
-542281500.0%
This company
8.1%
Market median
-6694833433% vs market
20202024
Asset turnover
-1.22×
This company
1.12×
Market median
-209% vs market
20202024
Debt / equity
0.35×
This company
0.62×
Market median
+44% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2019-09-23 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SS Management | Management | 2019 | — | — |
GM Founder | Founder | 2019 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MW | Board of Directors | 2023 | — | — |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2024 | — | — | |
| Chairman | 2021 | — | — | |
| Chairman | 2024 | — | — | |
| Chairman | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2023 | |
| Individual | 50.0% | 50.0% | 2021 | |
Asteria Holdings ApS | Company | 15.0% | 15.0% | 2021 |
BII Holdings A/S | Company | 5.0% | 5.0% | 2021 |
GM Holdings ApS | Company | 15.0% | 15.0% | 2021 |
NOVO NORDISK FONDEN | Company | 10.0% | 10.0% | 2020 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Ensoma ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Stefano Stella | Management | 0 companies |
| Guillermo Montoya Blanco | Founder | 0 companies |
| Min Wang | Board of Directors | 0 companies |
| Elinor Kyonghae Shin | Board of Directors | 0 companies |
| John Stephen Cassidy | Board of Directors | 0 companies |
| Christian Schetter | Chairman | 0 companies |
| Mark David Chin | Board of Directors | 0 companies |
| Paula Alex Soteropoulos | Chairman | 0 companies |
| Gita Padmavathy Dittmar | Chairman | 0 companies |
| James William Burns | Chairman | 0 companies |
| Emile Fuad Nuwaysir | Chairman | 0 companies |